Uterine activity after oral mifepristone administration in human pregnancies beyond 41 weeks' gestation

Gynecologic and Obstetric Investigation

Volumn 65, Issue 2, 2008, Pages 112-115

  Fassett, Michael J ^a,b   Wing, Deborah A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b KAISER PERMANENTE   (United States)

Author keywords

Labor induction; Mifepristone; Uterine activity

Indexed keywords

MIFEPRISTONE; PLACEBO;

ADULT; ARTICLE; DRUG MECHANISM; FEMALE; HUMAN; LABOR INDUCTION; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL; UTERINE CERVIX RIPENING; UTERUS CONTRACTION;

ABORTIFACIENT AGENTS, STEROIDAL; ADMINISTRATION, ORAL; ADULT; CERVICAL RIPENING; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LABOR, INDUCED; MIFEPRISTONE; PREGNANCY; PREGNANCY, PROLONGED; UTERINE CONTRACTION;

EID: 40349113508     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000109167     Document Type: Article

References (13)

1. Edwards MS: Mifepristone: cervical ripening and induction of labor. Clin Obstet Gynecol 1996;39:469-473.
2. Chwalisz K: The use of progesterone antagonists for cervical ripening and as an adjunct to labour and delivery. Hum Reprod 1994;9:131-161.
3. Swahn ML, Bygdeman M: The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin. Br J Obstet Gynaecol 1988;95:126-134.
4. Frydman R, Lelaidier C, Baton-Saint-Mleux C, Fernandez H, Vial M, Bourget P: Labor induction at term with mifepristone (RU486): a double-blind, randomized, placebo-controlled study. Obstet Gynecol 1992;80:972-975.
5. Haluska GJ, Stanczyk FZ, Cook MJ, Novy MJ: Temporal changes in uterine activity and prostaglandin response to RU486 in rhesus macaques in late gestation. Am J Obstet Gynecol 1987;157:1487-1495.
6. Germain G, Philibert D, Pottier J, Moren M, Baulieu E, Sureau C: Effect of the antiprogesterone agent RU 486 on the natural cycle and gestation in intact cynomolgus monkeys; in Baulieu EE, Segal SJ (eds): The Antiprogestin Steroid RU486 and Human Fertility Control. New York, Plenum Press, 1985, pp 155-167 .
7. Giacalone PL, Daures JP, Faure JM, Boulot P, Hedon B, Laffargue F: The effects of mifepristone on uterine sensitivity to oxytocin and fetal heart rate patterns. Eur J Obstet Gynecol Reprod Biol 2001;97:30-34.
8. Berkane N, Verstraete L, Uzan S, Boog G, Bernard M: Use of mifepristone to ripen the cervix and induce labor in term pregnancies. Am J Obstet Gynecol 2005;192:114-120.
9. Wing DA, Fassett MJ, Mishell DR: Mifepristone for preinduction cervical ripening beyond 41 weeks' gestation: a randomized controlled trial. Obstet Gynecol 2000;96:543-548.
10. Bygdeman M, Swahn ML: Progesterone receptor blockage: effect on uterine contractility and early pregnancy. Contraception 1985;32:45-51.
11. Heikinheimo O: Clinical pharmacokinetics of mifepristone. Clin Pharmacokinet 1997;33:7-17.
12. Heikinheimo O, Kekkonen R, Lahteenmaki P: The pharmacokinetics of mifepristone in humans reveal insights into differential mechanisms of antiprogestin action. Contraception 2003;68:421-426.
13. Elliott CL, Brennand JE, Calder AA: The effects of mifepristone on cervical ripening and labor induction in primigravidae. Obstet Gynecol 1998;92:804-809.